22G-Adapt vs 22G-Franseen Needle Biopsy in EUS-Guided Tissue Acquisition of Solid Lesions

NANot yet recruitingINTERVENTIONAL
Enrollment

576

Participants

Timeline

Start Date

July 31, 2025

Primary Completion Date

September 30, 2026

Study Completion Date

December 10, 2026

Conditions
Pancreatic NeoplasmsMediastinal NeoplasmsAbdominal Neoplasm, Excluding Pancreas Neoplasm
Interventions
DEVICE

22G Franseen Needle Group

Fine-needle-biopsy (22G Franseen, Boston Scientific, Winston-Salem, USA)

DEVICE

22G Adapt Needle Group

Fine-needle-biopsy (22G Adapt, Micro.Tech Endoscopy, Nanjing, China)

Trial Locations (1)

430030

Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan

All Listed Sponsors
collaborator

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

OTHER

collaborator

The First Affiliated Hospital of Anhui Medical University

OTHER

collaborator

The First People's Hospital of Yunnan

OTHER

collaborator

The First Affiliated Hospital of University of Science and Technology of China

OTHER

lead

Huazhong University of Science and Technology

OTHER